Products/Health/Apellis

Apellis

Biotech company developing treatments for rare diseases and eye disorders

HealthRaised Acquired by Biogen for $5.6 billion

About

Biotech company developing treatments for rare diseases and eye disorders

Key Facts

Category
Health
Raised
Acquired by Biogen for $5.6 billion
Discovered via
newsletter:Substack newsletter

Links

Similar products worth knowing

Want products like this in your inbox every morning?

Five products. Every morning. Written by someone who actually cares whether they're good or not. Free forever, unsubscribe whenever.